Limited evidence for use of bioresorbable vascular scaffold (BVS) in ACS patients.
Eight patients had acute STEMI and underwent primary PCI with BVS.
No cases of worsening flow, scaffold thrombosis, TLR or death to 30 days post PCI.
Direct BVS deployment in ACS appears safe and feasible.